This is the current revision of this page, as edited by InternetArchiveBot (talk | contribs) at 00:30, 6 September 2024 (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5). The present address (URL) is a permanent link to this version.
Revision as of 00:30, 6 September 2024 by InternetArchiveBot (talk | contribs) (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound| Monoclonal antibody | |
|---|---|
| Type | Fab fragment |
| Source | Mouse |
| Target | cardiac myosin |
| Clinical data | |
| Trade names | Myoscint |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
|
| ChemSpider |
|
| UNII | |
| (what is this?) (verify) | |
Indium (In) imciromab (trade name Myoscint) is a mouse monoclonal antibody labelled with the radioisotope Indium-111. It was used for cardiac imaging, but withdrawn in 1993.
See also
References
- WHO Drug Information
- "DiagnosticImaging.com: Centocor withdraws imaging agent applications". Archived from the original on 2012-02-26. Retrieved 2009-10-17.
| Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Bone |
| ||||||||
| Musculoskeletal |
| ||||||||
| Circulatory |
| ||||||||
| Neurologic |
| ||||||||
| Angiogenesis inhibitor |
| ||||||||
| Growth factor |
| ||||||||
| |||||||||
 | This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it. |
 | This nuclear medicine article is a stub. You can help Misplaced Pages by expanding it. |